New Horizon Health Publicly Traded Corporation
Biotechnology company focused on early cancer screening technologies, particularly non-invasive diagnostic tests for colorectal cancer.
Employee Number:
967
Technology:
Diagnostic tests
Estimated Revenue:
~$100M
Founded Date:
2021